|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
C
|
|
INDICATIONS:
|
|
Dandruff |
|
Dermatitis, seborrheic |
|
Tinea versicolor |
| |
|
|
SIDE EFFECTS:
|
|
Skin irritation |
|
Unusual dryness or oiliness of hair or scalp |
|
Increase in normal hair loss |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
Inflammation or exudation of skin, acute |
|
|
ADULT DOSE:
|
|
Dandruff or
Seborrheic dermatitis-
Topical, to the scalp as a 1% lotion, two times a week; or topical, to the scalp as a 2.5% lotion, two times a week for two weeks and then at less frequent intervals of once a week or once every two or more weeks.
Note: The medication should not be used more frequently than required to maintain control.
Tinea versicolor-
Topical, to the body as a 2.5% lotion, once a day for seven days.
Note: The lotion should be applied to all affected areas, except for the face and genitals, and left on for 10 minutes. Then the medication should be thoroughly rinsed off. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Dandruff or
Seborrheic dermatitis or
Tinea versicolor-
Infants: Safety and efficacy have not been established.
Children: See Usual adult and adolescent dose. |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|